Christopher R. Loose, Chief Scientific Officer at Frequency Therapeutics, Inc. (FREQ), sold 2,717 shares at $0.46 ($1K) on 2023-07-28, disclosed to the SEC on 2023-07-31.
Scheduled sale ($1k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.53 | 1,373 | $728 | 54.1% |
| 2 | $0.46 | 1,344 | $618 | 45.9% |
| Total | $0.50 avg | 2,717 | $1K | 100% |
| Filing → |
| FREQ | SELL | 2023-07-21 | $2K | — | Filing → |
| FREQ | SELL | 2023-07-19 | $2K | — | Filing → |
| FREQ | SELL | 2023-07-17 | $1K | — | Filing → |